Litifilimab has the potential to be a first-in-class therapy targeting blood dendritic cell antigen 2 (BDCA2) in CLE, a chronic autoimmune skin disease that has a substantial impact on the daily life ...
The Punjab and Haryana High Court has enhanced compensation awarded to a motor accident victim from ₹52 lakh to ₹9.16 crore, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results